The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis.
Curr Med Res Opin
; 39(10): 1367-1374, 2023 Oct.
Article
in En
| MEDLINE
| ID: mdl-37675878
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Prognostic_studies
Language:
En
Journal:
Curr Med Res Opin
Year:
2023
Document type:
Article
Affiliation country:
Australia
Country of publication:
Reino Unido